Valuation: Philogen S.p.A.

Market Cap 855M 953M 791M 716M 1.34B 90.79B 1.35B 9.45B 3.77B 47.51B 3.58B 3.5B 151B P/E 2026 *
-27.2x
P/E 2027 * -42.6x
Enterprise Value 642M 716M 594M 538M 1B 68.19B 1.02B 7.1B 2.83B 35.68B 2.69B 2.63B 113B EV / Sales 2026 *
8.09x
EV / Sales 2027 * 14.5x
Free-Float
26.38%
Yield 2026 *
3.39%
Yield 2027 * 1.65%
1 day-1.18%
1 week-1.87%
Current month-6.67%
1 month-5.83%
3 months-12.50%
6 months+0.96%
Current year-9.87%
1 week 21
Extreme 21
21.95
1 month 21
Extreme 21
22.8
Current year 19.56
Extreme 19.56
26
1 year 19.56
Extreme 19.56
26
3 years 16.3
Extreme 16.3
27.8
5 years 13
Extreme 13
27.8
10 years 12.6
Extreme 12.6
27.8
Manager TitleAgeSince
Chief Executive Officer 63 2020-10-04
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO 55 -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 57 1995-12-31
Director/Board Member 63 1995-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
2/5/26 Sell

Director

800 0.0027%
5/28/24 Buy

Director

10,000 0.0342%
1/25/22 Buy

Director

3,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-1.18%-1.87%-11.76%+21.04% 953M
+0.65%-3.56%+33.53%+60.50% 63.48B
+1.76%+1.27%+11.82%+82.12% 54.55B
-0.94%+0.99%+10.45%+102.18% 53.59B
+1.87%+0.37%+27.29%+56.73% 44.75B
+2.23%-3.01%+18.30%+100.87% 41.62B
+0.40%-3.89%+220.99%+917.56% 39.91B
+0.64%-3.85%+11.71%+45.57% 32.47B
+29.06%+47.63%+107.12%+94.27% 26.7B
+3.72%-7.45%+24.25%-2.99% 23.36B
Average +3.85%-0.56%+45.37%+147.78% 38.14B
Weighted average by Cap. +3.07%-0.29%+47.02%+160.21%

Financials

2026 *2027 *
Net sales 79.41M 88.51M 73.42M 66.49M 124M 8.43B 126M 878M 350M 4.41B 332M 325M 14B 42.6M 47.48M 39.38M 35.67M 66.64M 4.52B 67.44M 471M 188M 2.37B 178M 174M 7.51B
Net income -32M -35.67M -29.59M -26.79M -50.06M -3.4B -50.66M -354M -141M -1.78B -134M -131M -5.64B -20.03M -22.33M -18.52M -16.78M -31.34M -2.13B -31.72M -221M -88.21M -1.11B -83.8M -82.03M -3.53B
Net Debt -213M -237M -197M -178M -333M -22.6B -337M -2.35B -937M -11.83B -890M -872M -37.54B -238M -265M -220M -199M -372M -25.27B -377M -2.63B -1.05B -13.23B -996M -975M -41.98B
Projected Income Statement - Annual - Philogen S.p.A.
Logo Philogen S.p.A.
Philogen SpA is an Italy-based company, operating in the biotechnology sector. The Company develops products and technologies for the diagnosis and therapy of serious human diseases. It has three anti-cancer antibody derivatives, produced with an in-house industrial process, into Phase I/II clinical studies. The majority of its technologies and products are based on high-affinity human monoclonal antibody fragments. Philogen SpA developed a patented technology, Iterative Colony Filter Screening, for the isolation of monoclonal antibodies, which requires neither immunization nor phage display. The Company's subsidiaries are Philotec, Philomed and Philochem. Philogen SpA is headquartered in Siena, Italy.
Employees
230
Date Price Change Volume
26-10-28 €21.00 -1.18% 4,281
26-10-27 €21.25 0.00% 5,772
26-10-26 €21.25 +0.71% 15,120
26-10-23 €21.10 -0.71% 5,324
26-10-22 €21.25 -0.70% 7,945
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Philogen S.p.A.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.25EUR
Average target price
28.33EUR
Spread / Average Target
+33.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Philogen S.p.A.
  1. Stock Market
  2. Stocks
  3. PHIL Stock